Scientists at Oregon Health & Science University report that they have successfully edited RNA in a living animal in such a way that the repaired RNA then corrected a mutation in a protein that gives rise to Rett syndrome, a debilitating neurological disorder.

"This is the first example of using programmable RNA editing to repair a gene in mouse models of a neurological disease," said Gail Mandel, Ph.D., senior author of the paper pubished in Cell Reports today. "This gives us an approach that has some traction."

Mandel and co-authors have been focused on engineering a way to repair the mutated MeCP2 protein at the level of RNA, which acts as a messenger that carries instructions from DNA to control the synthesis of proteins.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

Other scientists have used the programmable RNA editing repair technique to target muscular dystrophy and even hearing loss in genetically engineered mice. However, this is the first demonstration that the technique holds promise in neurological disorders rooted in genetic mutations spread across thousands of different cell types in the brain.

"We repaired the MeCP2 protein in three different distinct populations of neurons," Mandel said. "So it's possible that it would work throughout the brain, assuming we can deliver the editing components in a widespread manner."